Lunch Wrap: ASX takes a breather as lithium stocks come alive
The S&P/ASX 200 fell 0.10% at lunchtime after two days of record highs, with Brent crude rising toward US$83 a barrel following reports Iran plans to restrict shipping through the Strait of Hormuz. Lithium stocks rose, including PLS Group (+5%) and Liontown (+4%). James Hardie rose 4% on net sales up 64% to US$1.5b and adjusted EBITDA up 79% to US$422.1m; Nick Scali fell 5% after flat written sales orders. Charter Hall Retail REIT profit rose 78% to $389.4m; Woodside agreed to sell its 70% Calyp
How this was made

The 30-second read
Why it matters
Trader-relevant catalysts include JHX’s quarterly growth figures, NCK’s order-volume softness in the outlook section, and OMA’s near-term two-week window for first appraisal results. Lithium-linked names (PLS, LTR) are moving on improved lithium-price sentiment rather than new company fundamentals in this text.
Market read
Index direction is slightly negative, but multiple single-stock catalysts and lithium sentiment create pockets of tradable momentum.
What to watch
For NCK, the flat written sales order volumes are a demand signal; for OMA, the key is whether “first results” deliver scale and quality, not just drilling progress.
Background
The article is a lunchtime ASX market wrap that highlights sector moves (energy, banks, lithium) and several company-specific updates including quarterly results, outlook commentary, and project/divestment progress.
Ticker impact
James Hardie rose roughly 4% after reporting quarterly net sales up 64% to US$1.5B and adjusted EBITDA up 79%.
Near-term support likely, though the magnitude of any follow-through depends on how investors interpret the outlook section.
The article provides specific earnings figures and ties the stock’s move to the reported quarterly result.
Woodside Energy agreed to sell its 70% stake in the Calypso gas project to BP, with BP taking full ownership.
Likely modest market impact unless deal terms (price, timing) or strategic rationale shift expectations.
The article confirms the transaction and ownership outcome but withholds the price, limiting conviction on magnitude.
Emyria expanded its Empax clinic network in the June quarter while lifting patient receipts and treatment capacity.
Potential gradual support, but conviction is limited without quantified growth rates.
The article states directional improvements without the magnitude needed for a high-confidence trading call.
Market effects
Lithium-linked ASX names are bid on improved lithium-price sentiment, while banks drag the index amid broader risk tone.
Moves are concentrated in ASX 200 constituents and ASX small caps, affecting index direction intraday.
Brent strength and Strait of Hormuz risk are cited as the macro backdrop influencing energy and overall risk appetite.
Counterpoint
Lithium “come back to life” may be sentiment-driven and could fade quickly if lithium pricing expectations prove premature.
Key entities
- companyJames Hardie
Reported quarterly net sales and adjusted EBITDA growth, coinciding with a ~4% intraday jump.
- companyNick Scali
Full-year result looked strong, but FY27 written sales order volumes were flat, coinciding with a ~5% drop.
- companyOmega Oil and Gas
Drilling progress at Canyon-3 to 2,570m, with first results expected within two weeks.
- companyLiontown
Lithium sentiment-driven rally of about 4% tied to investors feeling better about lithium prices.
- companyWoodside Energy Group
Agreed to sell its 70% Calypso stake to BP, with BP to own the whole project.


